Bausch Health Companies Inc

BHC11 Dec 2024
Healthcare
$8.48
-0.02 (-1.65%)
Lowest Today
$8.18
Highest Today
$8.52
Today’s Open
$8.48
Prev. Close
$8.46
52 Week High
$11.46
52 Week Low
$3.96
To Invest in Bausch Health Companies Inc

Bausch Health Companies Inc

Healthcare
BHC11 Dec 2024
-0.02 (-1.65%)
1M
3M
6M
1Y
5Y
Low
$8.18
Day’s Range
High
$8.52
8.18
52 Week Low
$3.96
52-Week Range
52 Week High
$11.46
3.96
1 Day
-
1 Week
+2.27%
1 month return
-10.67%
3 month return
+30.28%
6 month return
+36.47%
1 Year return
+16.27%
3 Years return
-65.47%
5 Years return
-71.61%
10 Years return
-
Institutional Holdings
ICAHN CARL C
9.44
Goldentree Asset Management LP
7.99
Paulson & Company Inc
7.19
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
3.53
Vanguard Group Inc
3.14
Nomura Holdings Inc
3.08
Royal Bank of Canada
3.04

Market Status

Fundamentals
Market Cap
3141.93 mln
PB Ratio
18.78
PE Ratio
0
Enterprise Value
23814.8 mln
Total Assets
27350 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Organisation
Bausch Health Companies Inc
Employees
20270
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Thomas J. Appio
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities